BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 15.8%
BioAffinity Technologies (NASDAQ:BIAFW) Shares Down 15.8%
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares dropped 15.8% during mid-day trading on Wednesday . The company traded as low as $0.30 and last traded at $0.38. Approximately 8,092 shares traded hands during mid-day trading, a decline of 5% from the average daily volume of 8,522 shares. The stock had previously closed at $0.45.
bioAffinity Technologies Trading Down 15.8 %
The company has a fifty day moving average of $0.46.
Get bioAffinity Technologies alerts:Institutional Investors Weigh In On bioAffinity Technologies
An institutional investor recently bought a new position in bioAffinity Technologies stock. Armistice Capital LLC bought a new stake in shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 204,082 shares of the company's stock, valued at approximately $72,000.
bioAffinity Technologies Company Profile
(Get Rating)bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.
Featured Stories
- Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
- Bed Bath & Beyond Is Circling the Drain
- Allegro Microsystems Is A Well-Positioned Semiconductor Stock
- Scotts Miracle-Gro Hits Bottom, Reversal In Play
- Altria is a Great Recession Stock, Long-Term Outlook Uncertain
- Novavax Shares Jumped in January While Others Slipped
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) shares dropped 15.8% during mid-day trading on Wednesday . The company traded as low as $0.30 and last traded at $0.38. Approximately 8,092 shares traded hands during mid-day trading, a decline of 5% from the average daily volume of 8,522 shares. The stock had previously closed at $0.45.
生物親和科技股份有限公司 (納斯達克:BIAFW — 獲取評級) 股價下降 15.8% 在星期三中午交易.該公司的交易價格低至 0.30 美元,最後交易價格為 0.38 美元。中間交易期間約 8,092 股交易手,較 8,522 股的平均每日成交量下降 5%。該股票以前已收盤 0.45 美元。
bioAffinity Technologies Trading Down 15.8 %
生物親和技術交易下跌 15.8%
The company has a fifty day moving average of $0.46.
該公司有一個五十天移動平均線 0.46 美元。
Institutional Investors Weigh In On bioAffinity Technologies
機構投資者權衡生物親和技術
An institutional investor recently bought a new position in bioAffinity Technologies stock. Armistice Capital LLC bought a new stake in shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Rating) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 204,082 shares of the company's stock, valued at approximately $72,000.
一名機構投資者最近購買了生物親和科技股票的新倉位。根據最近向證券交易委員會提交的 13F 表格,停戰資本有限責任公司在第三季度購買了生物聯合技術有限公司(NASDAQ:BIAFW-獲得評級)的股份的新股份。該基金買入了該公司股票的 204,082 股,價值約為 72,000 美元。
bioAffinity Technologies Company Profile
生物親和科技公司簡介
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level.
BioAffinity 科技有限公司是一家生物技術公司,致力於開發非侵入性診斷測試和靶向癌症治療。該公司提供 CypAth 肺部診斷 test,用於及早發現肺癌。它還研究標靶療法以治療細胞水平的癌症。
Featured Stories
特色故事
- Get a free copy of the StockNews.com research report on bioAffinity Technologies (BIAFW)
- Bed Bath & Beyond Is Circling the Drain
- Allegro Microsystems Is A Well-Positioned Semiconductor Stock
- Scotts Miracle-Gro Hits Bottom, Reversal In Play
- Altria is a Great Recession Stock, Long-Term Outlook Uncertain
- Novavax Shares Jumped in January While Others Slipped
- 獲取有關生物親和技術(BIAFW)的免費研究報告
- 床浴 & 超越是盤旋排水
- Allegro 微系統是定位良好的半導體股票
- 斯科茨奇蹟-格羅擊中底部,反轉在遊戲中
- 阿爾特里亞是一個巨大的經濟衰退股票,長期前景不確定
- 諾瓦克斯股價在 1 月份跳漲,而其他股票則下滑
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收生物親和技術的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 BioAffinity 技術和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧